At1g06470 Antibody

Shipped with Ice Packs
In Stock

Description

Overview of At1g06470

At1g06470 is an Arabidopsis gene encoding an integral membrane protein with eight putative transmembrane domains (TMDs) . The protein’s structure suggests potential roles in ion transport, receptor signaling, or membrane trafficking, though experimental validation is limited. Unlike well-characterized transporters (e.g., mitochondrial adenylate translocators or chloroplast envelope proteins), At1g06470 lacks definitive functional annotations .

Applications of At1g06470 Antibody

The At1g06470 antibody is primarily utilized for:

  • Subcellular localization studies: Confirming membrane association via immunofluorescence or immunogold labeling .

  • Protein-protein interaction assays: Identifying binding partners in pulldown or co-immunoprecipitation experiments.

  • Expression profiling: Tracking tissue-specific or stress-induced expression patterns.

Research Findings:

  • Proteomic Identification: At1g06470 was detected in tonoplast-enriched fractions, suggesting a role in vacuolar transport .

  • Developmental Regulation: Preliminary data indicate higher expression in root tissues, though quantitative validation is pending .

Challenges and Research Gaps

Despite its utility, the At1g06470 antibody faces limitations:

  1. Epitope Specificity: No published validation (e.g., knockout controls) confirms antibody specificity.

  2. Functional Data: No direct links to biochemical pathways or knockout phenotypes exist.

  3. Structural Insights: The absence of crystallography or cryo-EM data hinders mechanistic understanding.

Table 2: Critical Research Gaps

Gap AreaPriority LevelPotential Approaches
Functional validationHighCRISPR-Cas9 knockout lines, transport assays
Antibody validationMediumWestern blotting with mutant tissue
Interaction mappingHighYeast two-hybrid screens, affinity purification

Comparative Context

At1g06470 contrasts with better-studied membrane proteins in Arabidopsis:

  • AtAAC2 (At5g13490): A mitochondrial adenylate translocator with confirmed transport activity .

  • AtTic110 (At1g06950): A chloroplast inner envelope protein involved in protein import .

Unlike these proteins, At1g06470’s lack of homology to known transporters complicates functional predictions.

Future Directions

  • Systems Biology: Integrate transcriptomic and proteomic datasets to infer At1g06470’s regulatory networks.

  • Antibody Engineering: Develop monoclonal variants with improved specificity for high-resolution imaging.

  • Phenotypic Screens: Assess abiotic stress responses in At1g06470 knockdown lines.

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
At1g06470 antibody; F12K11.18 antibody; Probable sugar phosphate/phosphate translocator At1g06470 antibody
Target Names
At1g06470
Uniprot No.

Target Background

Database Links

KEGG: ath:AT1G06470

STRING: 3702.AT1G06470.1

UniGene: At.42340

Protein Families
TPT transporter family, TPT (TC 2.A.7.9) subfamily
Subcellular Location
Membrane; Multi-pass membrane protein.

Q&A

What is the At1g06470 Antibody and what is its target in Arabidopsis thaliana?

The At1g06470 Antibody (product code CSB-PA812768XA01DOA) targets the protein encoded by the At1g06470 gene in Arabidopsis thaliana (Mouse-ear cress), corresponding to UniProt accession number Q8H184 . This antibody is specifically designed for detecting this protein in plant tissue samples and is commonly used in molecular biology research focusing on Arabidopsis as a model organism. The At1g06470 gene encodes a protein involved in plant cellular processes, and the antibody allows researchers to study its expression, localization, and function through various immunological techniques.

How does epitope selection affect At1g06470 Antibody performance in different assays?

Epitope selection is critical for At1g06470 Antibody performance across different experimental applications. Most effective antibodies target unique, accessible epitopes that remain stable during sample processing. Different experimental conditions (native vs. denatured) affect epitope accessibility - some epitopes are only exposed after denaturation while others are conformational. When troubleshooting inconsistent results across immunoblotting, immunoprecipitation, and immunohistochemistry, researchers should consider that the epitope may be differentially accessible under various experimental conditions. This understanding follows principles similar to those used in developing other specialized antibodies, where careful epitope mapping significantly impacts antibody functionality across multiple assay formats.

What validation methods should be employed to confirm At1g06470 Antibody specificity?

Multiple complementary validation approaches should be implemented to confirm At1g06470 Antibody specificity:

  • Genetic knockouts/knockdowns: Compare antibody signal between wild-type plants and At1g06470 mutant lines

  • Recombinant protein analysis: Test against purified target protein

  • Western blot verification: Confirm single band of expected molecular weight

  • Immunoprecipitation followed by mass spectrometry: Identify all proteins captured by the antibody

  • Cross-reactivity testing: Evaluate against related Arabidopsis proteins

These validation methods align with best practices in antibody research that emphasize using multiple verification approaches rather than relying on a single technique, similar to methodologies described for therapeutic antibody validation programs that require comprehensive specificity testing .

How can At1g06470 Antibody be optimized for immunoprecipitation of protein complexes?

Optimizing At1g06470 Antibody for successful immunoprecipitation of protein complexes requires several methodological considerations:

  • Buffer system optimization: Test multiple lysis buffers with varying detergent concentrations (0.1-1% NP-40, Triton X-100, or digitonin) to preserve protein-protein interactions while ensuring efficient extraction

  • Cross-linking protocols: Implement in vivo formaldehyde cross-linking (0.5-1%) before cell lysis to stabilize transient interactions

  • Antibody coupling: Covalently couple the antibody to magnetic beads using dimethyl pimelimidate (DMP) to reduce antibody contamination in the final sample

  • Sequential elution strategy: Develop a stepwise elution protocol using increasing stringency to distinguish between direct and indirect interactions

  • Control experiments: Include parallel immunoprecipitations with non-specific IgG and test in At1g06470 knockout lines

This strategy follows principles similar to those applied in therapeutic antibody development where understanding protein-protein interactions is crucial for characterizing mechanism of action .

What are the considerations for using At1g06470 Antibody in CHIP-seq experiments?

When adapting At1g06470 Antibody for chromatin immunoprecipitation sequencing (ChIP-seq), researchers should address these critical factors:

  • Fixation optimization: Test formaldehyde concentrations (0.75-2%) and incubation times (5-20 minutes) to achieve optimal DNA-protein cross-linking without over-fixation

  • Sonication parameters: Optimize sonication conditions to achieve chromatin fragments of 200-500bp for high-resolution binding site identification

  • Antibody specificity validation: Perform control experiments using knockout lines and IgG controls to establish background levels

  • Input normalization: Collect input samples before immunoprecipitation to account for genomic biases

  • Technical replicates: Perform at least three biological replicates to ensure reproducibility

  • Sequencing depth: Aim for >10 million uniquely mapped reads for adequate coverage

This methodological approach aligns with established protocols for transcription factor ChIP-seq studies while addressing plant-specific challenges such as cell wall interference and endogenous plant phenolic compounds that can affect chromatin preparation.

How does post-translational modification affect At1g06470 Antibody recognition?

Post-translational modifications (PTMs) can significantly impact At1g06470 Antibody epitope recognition through several mechanisms:

  • Epitope masking: Phosphorylation, glycosylation, or other PTMs may directly modify or sterically hinder the epitope

  • Conformational changes: PTMs can alter protein folding, affecting conformational epitope accessibility

  • Variable detection across tissues: The same protein may carry different PTM profiles in different cell types or under various stress conditions

To address these challenges, researchers should:

  • Perform phosphatase or glycosidase treatments on samples to remove specific PTMs

  • Use complementary antibodies recognizing different epitopes

  • Consider developing modification-specific antibodies if particular PTMs are research-relevant

This approach mirrors strategies used in therapeutic antibody development where understanding epitope accessibility under various conditions is crucial for predicting antibody efficacy .

What strategies can resolve weak or inconsistent signals when using At1g06470 Antibody?

When encountering weak or inconsistent signals with At1g06470 Antibody, implement this systematic troubleshooting framework:

  • Sample preparation optimization:

    • Test multiple protein extraction buffers with different detergents

    • Add protease inhibitor cocktails to prevent degradation

    • Optimize plant tissue grinding methods for complete homogenization

  • Antibody incubation parameters:

    • Test concentration ranges (1:500 to 1:5000 dilutions)

    • Extend primary antibody incubation time (overnight at 4°C)

    • Try different blocking agents (5% BSA vs. non-fat milk)

  • Signal enhancement approaches:

    • Use high-sensitivity detection systems (chemiluminescence vs. standard colorimetric)

    • Implement signal amplification methods

    • Consider antigen retrieval techniques for fixed tissues

  • Expression level considerations:

    • Target protein may be naturally low-abundance

    • Expression may vary with developmental stage or environmental conditions

This methodological framework addresses the most common issues that affect antibody performance in plant systems based on principles similar to those used in antibody validation studies .

How can non-specific background be minimized when using At1g06470 Antibody in immunohistochemistry?

To minimize non-specific background in immunohistochemistry with At1g06470 Antibody:

  • Sample preparation refinement:

    • Optimize fixation protocol (test paraformaldehyde concentrations from 2-4%)

    • Implement antigen retrieval methods (citrate buffer at pH 6.0)

    • Test different embedding mediums for better tissue preservation

  • Blocking optimization:

    • Test extended blocking times (2-4 hours)

    • Use species-specific serum matching secondary antibody

    • Add 0.1-0.3% Triton X-100 to improve penetration

    • Include 0.1% BSA in wash buffers to reduce non-specific binding

  • Antibody parameters:

    • Titrate primary antibody concentration

    • Pre-absorb antibody with plant tissue powder from related species

    • Reduce incubation temperature (4°C overnight instead of room temperature)

  • Controls implementation:

    • Include secondary-only controls

    • Use tissue from At1g06470 knockout plants as negative control

    • Perform peptide competition assays

This approach addresses plant-specific challenges in immunohistochemistry, including autofluorescence from cell walls and chlorophyll.

What are the best storage and handling practices to maintain At1g06470 Antibody activity?

To preserve At1g06470 Antibody functionality over time:

  • Storage conditions:

    • Store antibody aliquots (10-50 μL) at -20°C for long-term storage

    • Avoid repeated freeze-thaw cycles (maximum 5 cycles)

    • For working solutions, store at 4°C with 0.02% sodium azide for up to 2 weeks

  • Stability enhancement:

    • Add stabilizing proteins (0.1-1% BSA) to diluted antibody

    • Consider adding glycerol (final concentration 30-50%) for freezer storage

    • Protect from light when fluorophore-conjugated

  • Quality control measures:

    • Document lot-to-lot variation with reference samples

    • Establish standard curves with positive controls

    • Periodically validate activity against fresh antibody

  • Transportation considerations:

    • Ship on ice or dry ice depending on duration

    • Monitor temperature during shipping

    • Allow antibody to equilibrate to room temperature before opening

These practices align with standard protocols for antibody maintenance and can significantly extend the functional lifespan of research antibodies.

How should researchers quantify protein expression levels using At1g06470 Antibody?

For accurate quantification of protein expression using At1g06470 Antibody:

  • Experimental design requirements:

    • Include technical triplicates and biological replicates (minimum 3)

    • Run concentration gradients of standard samples

    • Use appropriate loading controls (constitutively expressed proteins)

  • Image acquisition parameters:

    • Ensure signal is within linear detection range

    • Maintain consistent exposure settings across all samples

    • Capture sufficient technical replicates

  • Quantification methodology:

    • Normalize target protein signals to loading controls

    • Use densitometry software with background subtraction

    • Apply statistical analysis appropriate for experimental design

  • Reporting standards:

    • Present raw and normalized data

    • Include representative images with molecular weight markers

    • Report antibody dilution, exposure time, and detection method

This quantification framework ensures reproducibility and statistical validity of expression analyses using immunological detection methods.

How can researchers distinguish between specific and non-specific interactions in co-immunoprecipitation experiments with At1g06470 Antibody?

To distinguish genuine protein interactions from artifacts in co-immunoprecipitation experiments:

  • Control implementation:

    • Perform parallel IPs with non-specific IgG

    • Include samples from At1g06470 knockout/knockdown plants

    • Use reciprocal co-IP with antibodies against putative interacting partners

  • Stringency optimization:

    • Test different salt concentrations (150-500 mM NaCl) in wash buffers

    • Evaluate detergent stringency (0.1-1% NP-40 or Triton X-100)

    • Implement sequential elution with increasing stringency

  • Validation approaches:

    • Confirm interactions using orthogonal methods (e.g., proximity ligation assay)

    • Employ mass spectrometry to identify all co-precipitated proteins

    • Use recombinant protein binding assays to test direct interactions

  • Analysis framework:

    • Compare protein profiles across all control conditions

    • Apply statistical filters for enrichment over background

    • Consider known contaminants in plant IP experiments

This methodology aligns with best practices in protein interaction studies and helps minimize false positives that often confound co-immunoprecipitation experiments.

What strategies can resolve contradictory results between different detection methods using At1g06470 Antibody?

When confronted with contradictory results across different detection methods:

  • Epitope accessibility assessment:

    • Evaluate how different sample preparations affect epitope conformation

    • Consider that denatured vs. native conditions expose different epitopes

    • Test multiple antibodies targeting different regions of the same protein

  • Method-specific optimization:

    • Adjust fixation protocols for immunohistochemistry

    • Modify extraction buffers for Western blotting

    • Optimize detergent conditions for immunoprecipitation

  • Cross-validation framework:

    • Implement orthogonal detection methods (e.g., mass spectrometry)

    • Use genetic approaches (overexpression, knockdown) to validate antibody specificity

    • Consider reporter fusion proteins as complementary approach

  • Integration and interpretation:

    • Recognize that different methods reveal different aspects of protein biology

    • Document conditions that produce consistent results

    • Report discrepancies transparently in publications

This approach acknowledges that contradictory results often reflect biological reality rather than technical artifacts and provides a framework for comprehensive protein characterization.

How does At1g06470 Antibody performance compare across different Arabidopsis ecotypes and related plant species?

When using At1g06470 Antibody across different plant genetic backgrounds:

  • Sequence conservation analysis:

    • Analyze epitope sequence conservation across ecotypes and species

    • Predict potential cross-reactivity based on homology

    • Consider amino acid substitutions that might affect antibody binding

  • Empirical cross-reactivity testing:

    • Validate antibody performance in major Arabidopsis ecotypes (Col-0, Ler, Ws)

    • Test closely related Brassicaceae species

    • Establish detection limits for each species

  • Optimization for cross-species application:

    • Adjust antibody concentration based on sequence divergence

    • Modify stringency of washing steps for non-model species

    • Consider developing synthetic peptide standards for calibration

  • Interpretation guidelines:

    • Document species-specific band patterns or localization differences

    • Account for potential paralogous proteins in comparative analyses

    • Report normalized values when comparing across species

This comparative approach enables broader application of At1g06470 Antibody beyond its primary target organism while maintaining scientific rigor.

What novel techniques can enhance spatial resolution when using At1g06470 Antibody for protein localization?

Cutting-edge approaches to improve spatial resolution with At1g06470 Antibody include:

  • Super-resolution microscopy methods:

    • STORM (Stochastic Optical Reconstruction Microscopy): Achieves 20-30nm resolution

    • SIM (Structured Illumination Microscopy): Offers 100-120nm resolution with simpler sample preparation

    • Optimization of fluorophore selection for plant cell applications

  • Proximity labeling techniques:

    • APEX2 or BioID fusion proteins to identify spatial neighbors

    • Spatially-restricted enzymatic tagging of proteins in proximity to At1g06470

    • Correlation with antibody-based detection for validation

  • Correlative light and electron microscopy:

    • Immunogold labeling for TEM visualization

    • CLEM approaches to bridge scales from tissue to ultrastructural levels

    • Software tools for multi-scale image registration

  • Tissue-specific analysis approaches:

    • Laser capture microdissection combined with immunoblotting

    • Tissue clearing methods compatible with immunolabeling

    • Whole-mount immunostaining protocols for intact organs

These advanced techniques parallel methodologies used in therapeutic antibody development where precise localization can inform mechanism of action studies .

How might sequence-based antibody design tools improve next-generation At1g06470 Antibodies?

Emerging computational approaches offer significant potential for developing enhanced At1g06470 Antibodies:

  • AI-driven epitope prediction:

    • Deep learning algorithms can identify optimal epitopes with improved specificity

    • Models incorporate protein structure prediction for conformational epitopes

    • Sequence-based design tools like DyAb predict antibody properties from sequence data

  • Rational antibody engineering:

    • Structure-guided modifications to enhance affinity and specificity

    • Complementarity-determining region (CDR) scanning to optimize binding

    • Systematic mutation of residues in antibody CDRs to enhance performance

  • In silico cross-reactivity assessment:

    • Proteome-wide screening for potential off-targets

    • Prediction of binding to protein isoforms or closely related family members

    • Computational assessment of epitope conservation across species

  • Performance prediction:

    • Modeling antibody behavior under different experimental conditions

    • Predicting stability and shelf-life characteristics

    • Correlation between sequence properties and functionality in different assays

These computational approaches represent the frontier of antibody development and may address many current limitations of plant research antibodies.

What emerging applications might benefit from At1g06470 Antibody beyond traditional immunological techniques?

Beyond conventional applications, At1g06470 Antibody could be leveraged for:

  • Single-cell proteomics:

    • Antibody-based microfluidic sorting of specific cell populations

    • Single-cell Western blotting for heterogeneity analysis

    • Mass cytometry (CyTOF) for multi-parameter cellular analysis

  • Biosensor development:

    • FRET-based sensors utilizing antibody fragments

    • Surface plasmon resonance platforms for continuous monitoring

    • Antibody-functionalized nanomaterials for in vivo imaging

  • Synthetic biology applications:

    • Antibody-based modulation of protein function

    • Construction of artificial protein networks using antibody-based scaffolds

    • Targeted protein degradation systems using antibody-degrader conjugates

  • Environmental monitoring:

    • Field-deployable immunochromatographic assays

    • Antibody-functionalized electrochemical sensors

    • Remote detection systems for agricultural applications

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.